Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,009.50    -16.50 (-1.61%)
Bid:
1,014.50
Ask:
1,015.50
Spread: 1.00 (0.099%)
Market Cap: £4.97b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Final Terms

10 Jul 2026 17:35

RNS Number : 9659L
Babcock International Group PLC
10 July 2026
 

 

 

10 July 2026

Babcock International Group PLC

 

BABCOCK INTERNATIONAL GROUP PLC £250 million BOND ISSUE

Babcock International Group ('the Group' or 'Babcock') announces the issue of £250 million of five-year bonds carrying fixed coupon of 5.125%, the Group's first bond issue for seven years, to refinance the £300 million bond maturing in October 2026.

 

Babcock's strong proposition, fundamentals and balance sheet, combined with leading market positioning in defence and nuclear, has led to a high level of demand, allowing us to price on attractive terms.

 

The net proceeds of the issue will be used for general corporate purposes, including ongoing investment to support and drive growth.

 

BABCOCK ANNOUNCES PUBLICATION OF FINAL TERMS

The final terms dated 10 July 2026 (the "Final Terms") relating to the issue by Babcock on 14 July 2026 of GBP 250,000,000 5.125% per cent notes due 2026 (the "Notes") have been submitted to the UK Listing Authority and are available for viewing.

The Notes have been issued pursuant to the base prospectus dated 3 March 2026 (the "Base Prospectus") relating to the £3,000,000,000 Euro Medium Term Note Programme (the "Programme") of Babcock.

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/9659L_1-2026-7-10.pdf

A copy of the Final Terms has been submitted to the National Storage Mechanism and will be available at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information please contact:

 

Andrew Gollan

Samuel MacGregor

Director of Investor Relations

Investor Relations Manager

Tel: (0)7936 039004

Tel: (0)7730 753159

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain whether or not you are part of the intended addressees of the information contained therein.

In particular, the Prospectus does not constitute an offer of securities for sale in the United States. This is not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States and securities in bearer form are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered, sold or (in the case of securities in bearer form) delivered within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTRMMFTMTJBBBF
Date   Source Headline
31st Jul 20239:22 amRNSAnnual Financial Report
20th Jul 20237:16 amRNSFull year results for the year ended 31 March 2023
11th Jul 20237:00 amRNSDate of publication of FY23 preliminary statement
24th May 20238:54 amRNSDirectorate Change
20th Apr 20237:00 amRNSFY23 post close update and Type 31 contract update
1st Mar 20237:00 amRNSDisposal programme successfully concluded
15th Feb 20239:09 amRNSBabcock awarded contract to operate Skynet
2nd Feb 20238:13 amRNSDirectorate Change
20th Dec 202212:54 pmRNSStandard & Poor credit rating upgrade
9th Dec 20229:29 amRNSHolding(s) in Company
8th Dec 20229:06 amRNSHolding(s) in Company
22nd Nov 20227:00 amRNSHalf-year Report
9th Nov 20224:48 pmRNSHolding(s) in Company
3rd Nov 202212:13 pmRNSRestatement of pass-through revenue for HY22
3rd Nov 202211:08 amRNSRestatement of H1 2022 Results
21st Oct 20228:05 amRNSContract Win
18th Oct 20229:00 amRNSDirector appointment
13th Oct 202210:41 amRNSHolding(s) in Company
26th Sep 20224:00 pmRNSResult of AGM
26th Sep 20227:00 amRNSAGM Trading Update
12th Sep 20221:25 pmRNSNotice of AGM
25th Aug 202210:23 amRNSDirectorate Change
15th Aug 20225:14 pmRNSNotice of Availability
2nd Aug 20221:09 pmRNSDirector/PDMR Shareholding
29th Jul 20224:02 pmRNSCORRECTION: Full year results year ended 31.03.22
28th Jul 20227:00 amRNSFull year results for the year ended 31 March 2022
19th Jul 20227:00 amRNSSale of part of aerial emergency services business
20th Apr 202212:26 pmRNSDirector Declaration
6th Apr 202210:29 amRNSDirector Declaration
5th Apr 20229:16 amRNSHolding(s) in Company
28th Mar 202211:24 amRNSHolding(s) in Company
14th Mar 202210:00 amRNSCompletion of acquisition of NSM joint venture
7th Mar 202210:26 amRNSHolding(s) in Company
2nd Mar 20229:23 amRNSHolding(s) in Company
25th Feb 20227:00 amRNSTrading Update
15th Feb 20227:00 amRNSBabcock to acquire balance of Australian naval JV
10th Feb 202210:05 amRNSHolding(s) in Company
10th Feb 20227:00 amRNSCompletion of sale of stake in AirTanker Holdings
4th Feb 202210:00 amRNSDirectorate Change
2nd Feb 20228:58 amRNSHolding(s) in Company
24th Jan 202211:04 amRNSDirector/PDMR Shareholding
13th Jan 20228:48 amRNSHolding(s) in Company
10th Jan 20221:18 pmRNSHolding(s) in Company
6th Jan 20227:00 amRNSDirector Appointment
24th Dec 20217:00 amRNSCompletion of the sale of UK Power business
14th Dec 20214:08 pmRNSHolding(s) in Company
7th Dec 20217:00 amRNSHalf-year Report
6th Dec 202110:20 amRNSRestatement of results for HY ended 30 Sept 2020
16th Nov 202111:31 amRNSHolding(s) in Company
8th Nov 20214:44 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.